Genitourinary Cancer Program
Accelerating Access to Genitourinary Cancer Diagnosis and Treatment
About Our Program
The Genitourinary Cancer Program at City of Hope® Cancer Center Phoenix is committed to offering state-of-the-art diagnostic tools and treatment options for patients with cancer. Our multidisciplinary team of board-certified medical oncologists, surgical oncologists, radiation oncologists and urologists work collaboratively with our supportive care providers and each patient to deliver quality clinical care with a patient-centered approach.
Meet Our Experts
Our program is comprised of a multidisciplinary team of experts specializing in genitourinary cancer, including surgeons, medical and radiation oncologists, interventional radiologists, supportive care team members and more. Several of our physicians hold faculty positions within City of Hope and externally have obtained unique certifications.
Alan H. Bryce, M.D.
Chief Clinical Officer and Interim President
Medical Oncologist
Professor, Department of Molecular Medicine at Translational Genomics Research Institute (TGen)
Alan H. Bryce, M.D., joined City of Hope® Cancer Center Phoenix as the chief clinical officer in 2023 and is currently the interim president of City of Hope Phoenix. As a medical oncologist and researcher, Dr. Bryce holds a dual title as professor of the Department of Molecular Medicine at Translational Genomics Research Institute (TGen), also part of City of Hope and located in Phoenix. As an oncologist with City of Hope Phoenix, Dr. Bryce focuses his practice on genitourinary cancers, primarily prostate and testicular cancers, with specialized expertise in cancer research and genomics in prostate cancer.
Farshid Sadeghi, M.D.
Chief of Surgery
Urologic Oncology Surgeon
Assistant Clinical Professor, Department of Surgery
Farshid Sadeghi, M.D., is the chief of surgery and a urologic oncologist at City of Hope Phoenix, where he works with patients diagnosed with a variety of genitourinary conditions, including kidney, bladder and prostate cancer. He is a board-certified urologist with more than 25 years of experience in cancer care and research.
Paul Gellhaus, M.D.
Medical Director of the Genitourinary Program
Urologic Surgical Oncologist
Associate Clinical Professor, Department of Surgery
Paul Gellhaus, M.D., is an associate clinical professor of surgery and director of robotic surgery at City of Hope Phoenix. A recognized leader in urologic oncology and robotic (minimally invasive) surgery, Dr. Gellhaus brings innovative treatment options to patients with genitourinary and urologic disorders, including kidney, ureteral, testicular, prostate and bladder cancers.
Firas Shadad, M.D.
Medical Oncologist
Assistant Clinical Professor, Department of Medical Oncology & Therapeutics Research
Firas Shadad, M.D., is a board-certified medical oncologist specializing in treating genitourinary and gastrointestinal cancers at City of Hope Phoenix. Dr. Shadad takes a compassionate approach to care that involves collaborating with patients, their loved ones and other physicians to create a personalized treatment plan tailored to each patient’s needs, preferences and treatment goals. He has experience with cancer types ranging from bladder, prostate and kidney cancer to colorectal and pancreatic cancer.
Divneet Mandair, M.D., M.S.
Medical Oncologist
Associate Clinical Professor, Department of Medical Oncology & Therapeutics Research
As a medical oncologist at City of Hope Phoenix, Divneet Mandair, M.D., M.S., brings both his clinical and research expertise to his work with patients diagnosed with prostate cancer, bladder cancer and other genitourinary diseases. His goal for his patients is to create personalized and effective treatment plans that incorporate the latest research advances. Dr. Mandair pairs his compassionate approach to care with a deep knowledge of innovative treatment options, such as radiology therapy and PARP inhibitors for prostate cancer.
Refer a Patient to City of Hope
We strive to offer a well-coordinated experience for our referring providers. Upon receiving your referral, our team will immediately begin processing it, with minimal work on your end.
Address
14200 West Celebrate Life Way
Goodyear, AZ 85338
Institutional Distinctions
Delivering tomorrow's advances in cancer care to those who need them today, City of Hope has the following institutional distinctions.
Through our coast-to-coast clinical network, experts at City of Hope Phoenix and across the City of Hope system collaborate to deliver groundbreaking research and discuss lifesaving care, like never before.
City of Hope surgeons have performed over 11,000 robotic procedures, offering surgical precision, reduced postoperative pain and more rapid recovery.
Through offerings like our prostate clinical program for patients — City of Hope is one the first cancer centers in the United States to perform robotic-assisted prostatectomy using the da Vinci Surgical System, starting in 2003.
City of Hope delivers an accelerated bench-to-bedside approach, powered by three state-of-the-art, Good Manufacturing Practice-certified facilities at our core.
City of Hope is a leader in treating life-threatening diseases, including genitourinary cancers, for more than 100 years.
City of Hope patients have access to a diverse portfolio of genitourinary oncology clinical trials, including immunotherapy and stem cell treatments.
Blue Light Cystoscopy
Having expedited access to care excellence at City of Hope, the urologists with the Genitourinary Cancer Program at City of Hope are armed with blue light cystoscopy, an innovative diagnostic technology that significantly enhances bladder cancer detection.
City of Hope is proud to be the first facility in the West Valley to offer this state-of-the-art diagnostic tool, joining a select group of institutions in Arizona. Traditionally, most bladder cancer diagnoses rely on white light cystoscopy, which has long been the gold standard for visually inspecting the bladder lining. Blue light cystoscopy, when used in conjunction with white light, provides an enhanced visualization technique, improving the detection of non-muscle-invasive bladder cancer that might otherwise go unnoticed. patients are transferred directly to the genitourinary unit at our cancer center in Goodyear, Arizona, where our doctors use blue light cystoscopy to help detect genitourinary cancers.
Our Services and Offerings
At City of Hope, our physicians and clinical experts diagnose and treat a variety of types and stages of cancers, including relapsed or refractory disease.
Our Commitment to Clinical Excellence
Our Phoenix Program offers a dedicated multidisciplinary team that blends innovative research discoveries with superior clinical treatments. Since genitourinary diseases may frequently be treated by multiple modalities, there is deliberate collaboration between physicians and advanced practice providers to optimize clinical outcomes. The result is improved outcomes for patients with various genitourinary malignancies and other internal disorders. Additionally, our program is:
- Accredited by FACT — the Foundation for the Accreditation of Cellular Therapy —, a distinction given only to facilities that meet the highest standards in clinical care for adult allogeneic and autologous stem cell therapy, immune effector cell therapy, cell therapy product collection and cell therapy product processing
- Certified by the American Society of Clinical Oncology Quality Oncology Practice Initiative Certification Program, which is awarded to hospitals that demonstrate a commitment to quality along nationally approved standards
- Accredited by the College of American Pathologists (CAP), including recognition for biorepository services for tissue collection, preparation, sampling and processing at our laboratory (fewer than 100 CAP-accredited biorepository programs in the United States hold this distinction)
Latest Genitourinary Cancer News
Dedication to Speed to Care
City of Hope Cancer Center and our outpatient locations are intentionally structured to maximize speed to care, with: